Effects of A2 Dairy Consumption in Celiac Adolescents
The goal of this clinical trial is to evaluate the effect of A2 β-casein-containing milk and dairy product consumption on nutritional status, gastrointestinal symptoms, quality of life, sleep quality, and selected biochemical parameters in adolescents aged 10-18 years with celiac disease.
The main questions it aims to answer are:
* Does consumption of A2 β-casein-containing milk and dairy products improve gastrointestinal symptoms and quality of life in adolescents with celiac disease?
* Does consumption of A2 β-casein-containing milk and dairy products affect nutritional status, body composition, and biochemical parameters compared with standard milk and dairy products?
Researchers will compare adolescents consuming A2 β-casein-containing milk and dairy products with adolescents consuming standard milk and dairy products to see if A2 β-casein provides additional benefits.
Participants will:
* Consume the assigned milk and dairy products during the intervention period.
* Attend baseline and follow-up assessments.
* Complete dietary records and questionnaires related to gastrointestinal symptoms, sleep quality, and quality of life.
* Undergo anthropometric, body composition, hand grip strength, and biochemical assessments.
Gender: All
Ages: 10 Years - 18 Years
Celiac Disease
Celiac Disease in Children
A2 β-casein-containing Milk and Dairy Products